過敏診斷的全球市場:市場規模，佔有率，成長分析，各產品、服務(消耗品，設備)，各過敏原，各檢驗類型(生物內檢驗)，各終端用戶-產業預測(2022年～2028年)

Global Allergy Diagnostics Market Size, Share, Growth Analysis, By Product & Service(Consumables, Instruments, By Allergen, By Test Type(In Vivo Tests, By End User - Industry Forecast 2022-2028

出版日期: 2022年10月23日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球過敏診斷的市場規模，從2021年的48億美元，2028年成為100億3,000萬美元，從2022年到2028年的預測期間內的年複合成長率成為11.10％。過敏，職業暴露，對室內外的大氣污染的暴露增加，汽車造成的大氣污染，促進市場成長。

本報告提供全球過敏診斷市場的相關調查，市場概要，市場分析，企業簡介等全面性資訊。

市場動態
促進因素
機會
阻礙因素
課題
法規情形
SWOT分析
波特五力分析
- 競爭企業間的敵對關係
- 替代品的威脅
- 買方議價能力
- 新加入業者的威脅
- 供給企業談判力
- 政治影響
- 經濟影響
- 社會影響
- 技術性影響
- 環境的影響
- 法律上的影響

全球過敏診斷市場:各產品、服務

市場概要
消耗品
設備
免疫測量分析儀
ELISA分析儀
光度計
其他的設備
服務

全球過敏診斷市場:各過敏原

市場概要
吸入過敏原
食物過敏原
藥物過敏原
其他的過敏原

全球過敏診斷市場:各檢驗類型

市場概要
生物內檢驗
皮膚點刺測試
貼布測試
其他的生物內實驗
生物外實驗

全球過敏診斷市場:各終端用戶

市場概要
診斷檢驗室
醫院為基礎的檢驗室
學術、研究機關
其他的終端用戶

全球過敏診斷市場規模:各地區

市場概要
北美
美國
加拿大
歐洲
德國
西班牙
法國
英國
其他的歐洲
亞太地區
中國
印度
日本
韓國
其他的亞太地區
南美
巴西
其他的南美
中東、非洲
GCC各國
南非
其他的中東、非洲

競爭情形

主要5家公司的比較
主要企業的市場定位(2021年)
主要的市場參與企業採用的策略
主要成功策略
各開發
各企業
各年度
市場上最近的活動
主要企業的市場佔有率(%)(2021年)

主要企業簡介

Thermo Fisher Scientific Inc.(美國)
Siemens Healthineers(德國)
Danaher(美國)
Omega Diagnostics Group PLC(英國)
BioMerieux SA(法國)
Romer Labs Division Holding(奧地利)
EUROIMMUN Medizinische Labordiagnostika AG(德國)
HollisterStier Allergy(美國)
NEOGEN Corporation(美國)
Minaris Medical America, Inc.(美國)
Stallergenes Greer(英國)
HOB Biotech Group Corp., Ltd.(中國)
HYCOR Biomedical(美國)
R-Biopharm AG(德國)
AESKU.GROUP GmbH(德國)
ACON Laboratories, Inc.(美國)

簡介目錄

Product Code: SQSG35I2040

Global Allergy Diagnostics Market was valued at USD 4.80 billion in 2021, and the market size is estimated to reach USD 10.03 billion by 2028, at a CAGR of 11.10% over the forecast period (2022-2028).

The market for allergy diagnostics is anticipated to grow as pollution levels rise. Exposure to allergens, occupational exposure, and exposure to indoor and outdoor air pollution are the key risk factors for chronic respiratory infections. City inhabitants are more likely to have allergy disorders than rural dwellers are because they are exposed to more pollution. The market for allergy diagnostics is anticipated to develop as food allergies become more prevalent.

A type of allergic illness known as food allergy is more prevalent in urban and first-world nations than in rural areas and third-world nations. The hygiene standards and the likelihood of contracting infectious diseases are two of the most obvious disparities between these areas. The development of the immune system is probably influenced by early exposure to bacterial, viral, and parasite illnesses as well as to a number of common human body microorganisms. The incidence of sensitive skin and its propensity for irritation have increased as a result of climate change, air pollution, the complexity of materials, and cosmetic goods. These elements are anticipated to fuel the allergy diagnostics market's expansion in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Allergy Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The global Allergy Diagnostics market is segmented based on product & service, allergen, test type, end user, and region. Based on product & service, the Allergy Diagnostics market is segmented into Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments), Services. Based on allergen, the Allergy Diagnostics market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens. Based on test type, the Allergy Diagnostics market is segmented into In Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests. Based on end user, the Allergy Diagnostics market is segmented into Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users. Based on region, the Allergy Diagnostics market is categorized into North America, Europe, Asia-Pacific, and MEA.

Driver

Allergies, occupational exposure, and exposure to indoor and outdoor air pollution are the key risk factors for chronic respiratory illnesses. Due to greater exposure to environmental toxins in cities, there are more people with allergy problems in urban areas than in rural areas (as a result of vehicular pollution and industrial activities). More than 80% of people who live in urban areas, according to the WHO, are exposed to air quality levels that exceed WHO safety recommendations; while this is a global trend, the effects are more severe in urban areas of low-income nations. Since that air pollution from automobiles has been identified as a major risk factor for allergic disorders, this is an important indicator for the development of the market for allergy diagnostics.

Restraint

Industry participants regularly update a number of allergy diagnostic equipment, including luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers. These instruments are more expensive because they have numerous features and functionality (the price of each instrument varies based on its accuracy, flexibility, and TAT). For instance, the price of an immunoassay analyzer ranges from $10,000 to $20,000, whereas the price of a luminometer is between $3,000 and $14,000. Fully automated analyzers start at around USD 14,000 while semi-automatic ELISA readers cost between USD 2,000 and USD 5,000. In addition, there are expenses related to running this equipment such as maintenance and insurance, laboratory supervision, and overheads (such as utilities, space, and administration).

Market Trends

Reagent leasing contracts are becoming more popular as a way to lower the high cost of allergy diagnosis. Reagent rental contracts are sales agreements between manufacturers of allergy diagnostic products and end users (such as hospitals and diagnostic laboratories). By entering into a reagent-purchase contract with the producer, the end user leases or purchases instruments at a discounted price under these arrangements. By reducing the end user's initial capital investment and guaranteeing the manufacturer long-term orders, this agreement benefits both parties. In some cases, end users can rent analyzers on a per-test basis. Labs can significantly reduce costs by using cost-per-test contracts and reagent leasing agreements. Also, they help laboratories avoid significant fixed capital expenditures related to the purchase of new equipment. High-volume laboratories incur much higher expenditures than standard laboratories. The average contract lasts between five and ten years, so laboratories may stay current on the most recent developments in allergy diagnosis. Some contracts include service/maintenance fees as part of the total price, giving laboratories an additional savings.